Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Schurr

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Harefuah|September 6, 2014
[Statins and muscle pain]Yoni Yosef, Daniel Schurr, Naama Constantini
Harefuah|March 22, 2021
[TREATMENT OF HOMOZYGOTES OF FAMILIAL HYPERCHOLESTEROLEMIA: RECOMMENDATIONS OF THE ISRAELI SOCIETY OF ATHEROSCLEROSIS]Hofit Cohen, Ronen Durst, Avishay Elis, et al.
Journal of Clinical Apheresis|November 21, 2009
Long-term plasma exchange for severe refractory hypertriglyceridemia: a decade of experience demonstrates safety and efficacyMichal Schaap-Fogler, Daniel Schurr, Tova Schaap, et al.
The Israel Medical Association Journal : IMAJ|December 3, 2003
Pre-placement screening in international adoptionGary W Diamond, Yehuda Senecky, Daniel Schurr, et al.
Clinical Endocrinology|May 16, 2020
A rare frameshift mutation in the AGPAT2 gene in a family from gaza with congenital generalized lipodystrophyKobi Gorin, Mordechai Golomb, Shoshi Spitzen, et al.
The Israel Medical Association Journal : IMAJ|November 21, 2002
One year experience with a low density lipoprotein apheresis systemRonen Durst, Deborah Rund, Daniel Schurr, et al.
The Journal of Pediatrics|November 3, 2009
Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemiaEvan A Stein, A David Marais, Tamas Szamosi, et al.
Journal of Lipid Research|August 8, 2019
In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in <i>MTTP</i> explain only part of LDL variability in an FH familyMichael Winther, Shoshi Shpitzen, Or Yaacov, et al.
Atherosclerosis|January 21, 2017
Molecular genetics of familial hypercholesterolemia in Israel-revisitedRonen Durst, Uche Ken Ibe, Shoshi Shpitzen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Harefuah|September 6, 2014
[Statins and muscle pain]Yoni Yosef, Daniel Schurr, Naama Constantini
Harefuah|March 22, 2021
[TREATMENT OF HOMOZYGOTES OF FAMILIAL HYPERCHOLESTEROLEMIA: RECOMMENDATIONS OF THE ISRAELI SOCIETY OF ATHEROSCLEROSIS]Hofit Cohen, Ronen Durst, Avishay Elis, et al.
Journal of Clinical Apheresis|November 21, 2009
Long-term plasma exchange for severe refractory hypertriglyceridemia: a decade of experience demonstrates safety and efficacyMichal Schaap-Fogler, Daniel Schurr, Tova Schaap, et al.
The Israel Medical Association Journal : IMAJ|December 3, 2003
Pre-placement screening in international adoptionGary W Diamond, Yehuda Senecky, Daniel Schurr, et al.
Clinical Endocrinology|May 16, 2020
A rare frameshift mutation in the AGPAT2 gene in a family from gaza with congenital generalized lipodystrophyKobi Gorin, Mordechai Golomb, Shoshi Spitzen, et al.
The Israel Medical Association Journal : IMAJ|November 21, 2002
One year experience with a low density lipoprotein apheresis systemRonen Durst, Deborah Rund, Daniel Schurr, et al.
The Journal of Pediatrics|November 3, 2009
Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemiaEvan A Stein, A David Marais, Tamas Szamosi, et al.
Journal of Lipid Research|August 8, 2019
In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in <i>MTTP</i> explain only part of LDL variability in an FH familyMichael Winther, Shoshi Shpitzen, Or Yaacov, et al.
Atherosclerosis|January 21, 2017
Molecular genetics of familial hypercholesterolemia in Israel-revisitedRonen Durst, Uche Ken Ibe, Shoshi Shpitzen, et al.
Pageof 1